A. Lavagna

Infliximab and the risk of latent viruses reactivation in active Crohnʼs disease

A. Lavagna, Massimiliano Bergallo, Marco Daperno et al. · Inflammatory Bowel Diseases · 2007 · 92 citations · Full text

Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: Proposal of an ultrasonographic score

C. Rigazio, E. Ercole, C. Laudi et al. · Scandinavian Journal of Gastroenterology · 2009 · 88 citations

An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users

Enea Spada, D. Genovese, Maria Elena Tosti et al. · Journal of Hepatology · 2005 · 79 citations

Vaccination, Substance Abuse, Infectious Disease Prevention +11

Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study

Ambrogio Orlando, Elisabetta Colombo, Anna Kohn et al. · Digestive and Liver Disease · 2005 · 77 citations

Inflammation, Anti-inflammatory, Gastroenterology +4

Effectiveness of <i>Helicobacter pylori</i> eradication treatments in a primary care setting in Italy

P. Della Monica, A. Lavagna, G. Masoero et al. · Alimentary Pharmacology & Therapeutics · 2002 · 75 citations · Full text